Ding WJ - Search Results

1

Synergistic anti-cancer activity by the combination of TRAIL/APO-2L and celastrol.

Zhu H, Ding WJ, Wu R, Weng QJ, Lou JS, Jin RJ, Lu W, Yang B, He QJ. Zhu H, et al. Among authors: ding wj. Cancer Invest. 2010 Jan;28(1):23-32. doi: 10.3109/07357900903095664. Cancer Invest. 2010. PMID: 19916747

2

XN05, a novel synthesized microtubule inhibitor, exhibits potent activity against human carcinoma cells in vitro.

Wu R, Ding W, Liu T, Zhu H, Hu Y, Yang B, He Q. Wu R, et al. Cancer Lett. 2009 Nov 18;285(1):13-22. doi: 10.1016/j.canlet.2009.04.042. Epub 2009 Aug 3. Cancer Lett. 2009. PMID: 19647933

3

Synergistic antitumor effect of TRAIL in combination with sunitinib in vitro and in vivo.

Ding W, Cai T, Zhu H, Wu R, Tu C, Yang L, Lu W, He Q, Yang B. Ding W, et al. Cancer Lett. 2010 Jul 28;293(2):158-66. doi: 10.1016/j.canlet.2010.01.005. Epub 2010 Feb 6. Cancer Lett. 2010. PMID: 20137855

4

Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L.

Zhu H, Liu XW, Ding WJ, Xu DQ, Zhao YC, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: ding wj. Cancer Lett. 2010 Nov 28;297(2):155-64. doi: 10.1016/j.canlet.2010.04.030. Epub 2010 Jun 1. Cancer Lett. 2010. PMID: 20605676

5

HIF-1α-dependent autophagy protects HeLa cells from fenretinide (4-HPR)-induced apoptosis in hypoxia.

Liu XW, Su Y, Zhu H, Cao J, Ding WJ, Zhao YC, He QJ, Yang B. Liu XW, et al. Among authors: ding wj. Pharmacol Res. 2010 Nov;62(5):416-25. doi: 10.1016/j.phrs.2010.07.002. Epub 2010 Jul 15. Pharmacol Res. 2010. PMID: 20637870

6

GDC-0941 sensitizes breast cancer to ABT-737 in vitro and in vivo through promoting the degradation of Mcl-1.

Zheng L, Yang W, Zhang C, Ding WJ, Zhu H, Lin NM, Wu HH, He QJ, Yang B. Zheng L, et al. Among authors: ding wj. Cancer Lett. 2011 Oct 1;309(1):27-36. doi: 10.1016/j.canlet.2011.05.011. Epub 2011 Jun 12. Cancer Lett. 2011. PMID: 21664043

7

Upregulating Noxa by ER stress, celastrol exerts synergistic anti-cancer activity in combination with ABT-737 in human hepatocellular carcinoma cells.

Zhu H, Yang W, He LJ, Ding WJ, Zheng L, Liao SD, Huang P, Lu W, He QJ, Yang B. Zhu H, et al. Among authors: ding wj. PLoS One. 2012;7(12):e52333. doi: 10.1371/journal.pone.0052333. Epub 2012 Dec 20. PLoS One. 2012. PMID: 23284992 Free PMC article.

8

E2F1 impairs all-trans retinoic acid-induced osteogenic differentiation of osteosarcoma via promoting ubiquitination-mediated degradation of RARα.

Zhang L, Zhou Q, Zhang N, Li W, Ying M, Ding W, Yang B, He Q. Zhang L, et al. Cell Cycle. 2014;13(8):1277-87. doi: 10.4161/cc.28190. Epub 2014 Feb 17. Cell Cycle. 2014. PMID: 24608861 Free PMC article.

9

Physapubescin B Exhibits Potent Activity against Human Prostate Cancer In Vitro and In Vivo.

Ding W, Hu Z, Zhang Z, Ma Q, Tang H, Ma Z. Ding W, et al. J Agric Food Chem. 2015 Nov 4;63(43):9504-12. doi: 10.1021/acs.jafc.5b03045. Epub 2015 Oct 21. J Agric Food Chem. 2015. PMID: 26415552

10

Synergistic antitumor activity of DHA and JQ1 in colorectal carcinoma.

Ding W, Zhang H, Mei G. Ding W, et al. Eur J Pharmacol. 2020 Oct 15;885:173500. doi: 10.1016/j.ejphar.2020.173500. Epub 2020 Aug 27. Eur J Pharmacol. 2020. PMID: 32861663

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters